Central nervous system neurodegeneration and tinnitus: A clinical experience Part I: Diagnosis

International Tinnitus Journal

Volumn 13, Issue 2, 2007, Pages 118-131

  Shulman, Abraham ^a   Goldstein, Barbara ^b   Strashun, Arnold M ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b NONE

Author keywords

Central type, severe, disabling tinnitus; Inflammation; Ischemia; Medical audiological neurodegenerative profile; Neurodegeneration; Senile dementia of the Alzheimer's type

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; BRAIN ISCHEMIA; BRAIN PERFUSION; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROLOGIC EXAMINATION; NUCLEAR MEDICINE; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TINNITUS;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN ISCHEMIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE DEGENERATION; PREVALENCE; SEVERITY OF ILLNESS INDEX; TINNITUS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 37549017350     PISSN: 09465448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Sapolsky, RM. Neuroprotective gene therapy against acute neurological insults. Nat Rev Neurosci 4(1):61-69, 2003.
2. Shulman A. Medical significance of tinnitus. Int Tinnitus J 3(1):45-50, 1997.
3. Shulman A, Tonndorf J, Feldmann H, et al. In A Shulman, JM Aran, J Tonndorf, et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger, 1991.
4. Shulman A. Medical audiological evaluation of the tinnitus patients. Semin Hear 8(1):7-14, 1987.
5. Shulman A. Medical Audiologic Tinnitus Patient Protocol. In A Shulman, JM Aran, J Tonndorf, et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger, 1991:319-322.
6. Shulman A. Clinical classification of subjective idiopathic tinnitus. Laryngol Otol Suppl 4:123-129, 1981.
7. Shulman A. Subjective Idiopathic Tinnitus Clinical Types: A System of Nomenclature and Classification. In H Feldmann (ed), Proceedings of the Third International Tinnitus Seminar. Karlsruhe: Harsch Verlag, 1987:136-141.
8. Shulman A. Clinical Types of Tinnitus. In A Shulman, JM Aran, J Tonndorf, et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger, 1991:323-341.
9. Shulman A, Strashun AM, Afriyie M, et al. SPECT imaging of brain and tinnitus - neurootology neurologic implications. Int Tinnitus J 1(1):13-29, 1995.
10. Shulman A. Tinnitus neural substrates: An addendum. Int Tinnitus J 11(1):1-3, 2005.
11. Shulman A, Goldstein B. Quantitative electroencephalography: Preliminary report - tinnitus. Int Tinnitus J 8(2):77-86, 2002.
12. Shulman A, Avitable MJ, Goldstein B. Quantitative electroencephalography power analysis in subjective idiopathic tinnitus patients: A clinical paradigm shift in the understanding of tinnitus, an electrophysiologic correlate. Int Tinnitus J 12(2):121-132, 2006.
13. Van Marie HJF, Kronberg E, Schulman JJ, et al. Magnetoencephalographic Recordings from Tinnitus Patients during Masking Procedures. In H Novack, F Geissler, R Huonker (eds), BIOMAG 002. Berlin: VDE Verlag, 2002:191.
14. Newberg AB, Alavi A. Normal patterns and variants in SPECT/PET brain imaging. Semin Nucl Med 33:42-55, 2003.
15. Tikofsy RS, et al. Functional brain SPECT imaging. Nucl Med Ann 1933-1963, 1999.
16. Noback CR, et al. Functional Cerebral SPECT/PET Imaging, 3rd ed. RL Van Heertum, RS Tikofsky (eds), New York: Lippincott, Williams & Wilkins, 2000:35-54.
17. Matsuda H. Role of neuroimaging in Alzheimer's disease with emphasis on perfusion SPECT. J Nucl Med 48:1289-1300, 2007.
18. Shulman A. A final common pathway for tinnitus - medial temporal lobe system. Int Tinnitus J 1:115-126, 1995.
19. A-benzodiazepine- chloride receptor-targeted therapy for tinnitus control: Preliminary report. Int Tinnitus J 8:30-36, 2002.
20. Shulman A, Goldstein B. Tinnitus dyssynchrony theory: A translational concept for diagnosis and treatment. Int Tinnitus J 12(2):115-120, 2006.
21. Shulman A. Tinnitology, tinnitogenesis, nuclear medicine, and tinnitus patients. Int Tinnitus J 4(2):102-108, 1998.
22. Shulman A, Strashun AM, Seibyl JP, et al. Benzodiazepine receptor deficiency and tinnitus. Int Tinnitus J 6(2):98-111, 2000.
23. Daftary A, Shulman A, Strashun AM, et al. Benzodiazepine receptor distribution in severe disabling tinnitus. Int Tinnitus J 10(1):17-23, 2004.
24. Shulman A, Strashun AM. Descending auditory system/cerebellum/tinnitus. Int Tinnitus J 5(2):92-106,1999.
25. Shulman A. Efferent Auditory System Pathways and Tinnitus. In A Shulman, JM Aran, J Tonndorf, et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger, 1991:184-410.
26. Thompson, PM, et al. Tracking Alzheimer's Disease. Ann N Y Acad Sci 1097:183-214, 2007.
27. Claussen CF. Treatment of the slow-brainstem syndrome with Vertigoheel. Biologische Medizin 3:447-470, 4:510-514, 1985.
28. Claussen CF, Claussen E. The Syndrome of the Slow Brainstem. In CT Haid (ed), Vestibular Diagnosis and Neuro-Otosurgical Management of the Skull Base. Gräfelfing: Demeter Verlag, 1991:139-141.
29. Schneider D, Kolchev C, Constantinescu, L, Claussen CF. Vestibular evoked potentials (VestEP) and brain electrical activity mapping - a test of vestibular function. A review: 1990-1996. Int Tinnitus J 2(1):27-44, 1996.
30. Inzitari D. Leukoariosis: An independent risk factor for stroke? Stroke 34:2067-2071, 2003.
31. Esiri MM. The interplay between inflammation and neurodegeneration in CNS disease. J Immunol 184(1-2):4-16, 2007.
32. Shulman A. Medical Evaluation. In A Shulman, JM Aran, J Tonndorf, et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger, 1991:258-259.
33. van Dijk EJ, et al. The association between blood pressure, hypertension, cerebral white matter lesions. Hypertension 44:625, 2004.
34. Schwartz GL, Bailey KR, Mosley T, et al. Association of ambulatory blood pressure with ischemic brain injury. Hypertension 49(6):1228, 2007.
35. Matsushita K, et al. Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. Hypertension 23:565-568, 1994.
36. De Ridder D. Amygdohippocampal involvement in tinnitus and auditory memory. Acta Otolaryngol 126:50-53, 2006.